The Growing Global Threat Of Antibiotic Resistance Ielts Reading Answers Top //free\\ Direct

Combating this threat requires a multi-pronged approach (often termed a "One Health" approach):

Section C contrasts the different ways people acquire antibiotics based on geography and economic development.

explains the cessation of research by drug companies in the 1980s. Key Vocabulary to Master

International bodies such as the WHO, the Food and Agriculture Organization (FAO), and the World Organisation for Animal Health (OIE) have launched a Global Action Plan on AMR, which over 150 countries have signed. However, implementation remains inconsistent, particularly in low- and middle-income countries where regulatory oversight is weak and antibiotics are often available without a prescription. The COVID-19 pandemic demonstrated how quickly a global health threat can escalate when preparedness is lacking. Antibiotic resistance is slower moving, but far more insidious. It represents a silent pandemic—one that threatens to undo a century of medical progress. It represents a silent pandemic—one that threatens to

Antibiotic resistance is not a new phenomenon; it is a natural outcome of bacterial evolution. Even after the mass production of penicillin began in 1943, resistant strains started appearing within just four years. Today, the UN World Health Organization (WHO) warns that one in six bacterial infections globally are resistant to standard antibiotics.

What type of approach is recommended to address antibiotic resistance, acknowledging links between humans, animals, and the environment?

This text challenges students with dense scientific concepts and specific data interpretation. If you recently took a practice test on this topic, here is a breakdown of the common answers to help you understand the logic behind them. more potent medications.

Determining if a statement agrees with the writer's claims.

Compounding this crisis is the stagnation of the antibiotic pipeline. The ‘golden age’ of antibiotic discovery ended decades ago. Large pharmaceutical companies have largely abandoned antibiotic research due to poor financial incentives. A new cancer drug can be sold for thousands of dollars per dose and taken for months; a new antibiotic, by contrast, must be used sparingly to prevent resistance, and for short durations, making it far less profitable. Consequently, only two new classes of antibiotics have reached the market in the last 50 years. Even when new drugs are developed, resistant strains often emerge within a few years of their introduction.

| Word | Meaning | | :--- | :--- | | | Becoming weaker or smaller | | Rampant | Uncontrolled, widespread | | Reservoir | A large supply or source | | Insidious | Gradual, subtle, but harmful | | Stagnation | Lack of activity or development | | Incentives | Motivations or rewards | | Sparing | Using little of something | | Interconnectedness | Mutual connection between things | a new antibiotic

The economic consequences of using alternative, more potent medications. Questions 7–10

: Resistance is an evolutionary risk, but not a guaranteed consequence of every single dose.

A prediction regarding the future mortality rate of drug-resistant infections.